The EGF/ErbB receptor family and apoptosis

被引:94
作者
Danielsen, AJ [1 ]
Maihle, NJ [1 ]
机构
[1] Mayo Clin, Dept Biochem & Mol Biol, Tumor Biol Program, Rochester, MN 55905 USA
关键词
EGF; ErbB receptors; apoptosis; death signaling; survival signals; breast cancer;
D O I
10.1080/08977190290022185
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ErbB receptor family can activate a multitude of cell signaling pathways that involve many aspects of cellular function. The four members of the ErbB receptor family interact with diverse ligands and substrates, as well as with each other through cell surface heterodimerization. The sum of these diverse interactions is a signaling network that is complex but also finely regulated. Among the cellular functions influenced by ErbB signaling is cell survival. ErbB receptor signaling has been demonstrated to interact with all of the major mechanisms of cell death signaling in a manner that promotes cell survival. Survival factors such as Ras, PI3-K, Akt, and Bcl-x/-2 all have been shown to be activated by ErbB signaling (Fig. 5). ErbB abrogation of apoptotic signals has been shown to play an important role during embryonic tissue development, in normal adult tissue maintenance (e.g. mammary tissue, wound healing), and also in tumor development and progression. Although the majority of studies suggest that ErbB receptor family members are mediators of cell survival, there have been occasional reports suggesting that ErbB receptors can induce cell death under selected experimental conditions. While this apparent discrepancy remains unresolved, in many of these reports, cell death may be the result of anoikis in response to changes in the cytoskeleton associated with hyperstimulation of ErbB signaling. The notion that ErbB receptor family members function to promote cell survival is not a recent observation. However, how this family functions to prevent apoptosis is an area that only recently has been considered. The understanding of ErbB receptor signaling as it relates to the avoidance of apoptosis had profound implications for the treatment of solid tumors originating in multiple tissues, as well as for the treatment of neurodegenerative disease. Further elucidation of the complex relationships between ErbB receptor signaling networks and the apoptotic machinery is certain to yield biologically important and potentially life-saving information.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 202 条
  • [51] GEIER A, 1993, IN VITRO CELL DEV-AN, V29A, P231
  • [52] Epidermal growth factor protects epithelial cells against Fas-induced apoptosis - Requirement for Akt activation
    Gibson, S
    Tu, S
    Oyer, R
    Anderson, SM
    Johnson, GL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17612 - 17618
  • [53] EPIDERMAL GROWTH-FACTOR RECEPTOR IMMUNOREACTIVITY IN RAT-BRAIN - DEVELOPMENT AND CELLULAR-LOCALIZATION
    GOMEZPINILLA, F
    KNAUER, DJ
    NIETOSAMPEDRO, M
    [J]. BRAIN RESEARCH, 1988, 438 (1-2) : 385 - 390
  • [54] Epidermal growth factor (EGF)
    Goodlad, RA
    Wright, NA
    [J]. BAILLIERES CLINICAL GASTROENTEROLOGY, 1996, 10 (01): : 33 - 47
  • [55] Epidermal growth factor receptor-mediated Stat3 signaling blocks apoptosis in head and neck cancer
    Grandis, JR
    Zeng, Q
    Drenning, SD
    [J]. LARYNGOSCOPE, 2000, 110 (05) : 868 - 874
  • [56] Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
    Grandis, JR
    Drenning, SD
    Zeng, Q
    Watkins, SC
    Melhem, MF
    Endo, S
    Johnson, DE
    Huang, L
    He, YK
    Kim, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) : 4227 - 4232
  • [57] Gresik EW, 1998, EUR J MORPHOL, V36, P92
  • [58] BCL-2 family members and the mitochondria in apoptosis
    Gross, A
    McDonnell, JM
    Korsmeyer, SJ
    [J]. GENES & DEVELOPMENT, 1999, 13 (15) : 1899 - 1911
  • [59] Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
    Gross, A
    Jockel, J
    Wei, MC
    Korsmeyer, SJ
    [J]. EMBO JOURNAL, 1998, 17 (14) : 3878 - 3885
  • [60] Guerra-Vladusic FK, 1999, INT J ONCOL, V15, P883